针对皮肤状细胞癌的分子向疗法:最近的发展和临床影响
Harpreet Singh1, Hitesh Chopra2, Inderbir Singh3
1School of Pharmaceutical Sciences, IFTM University, Moradabad, U.P., India, 244102.
EXCLI journal
|April 24, 2024
概括
了解皮肤状细胞癌 (cSCC) 的分子基础是开发向治疗的关键. 本综述探讨了cSCC的发病性,分子点和克服治疗耐药性的策略.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
背景情况:
- 皮肤状细胞癌 (cSCC) 是一种流行且潜在致命的皮肤癌.
- 紫外线辐射暴露和遗传综合征增加cSCC风险.
- 目前的疗法面临局限性,需要新的治疗策略.
研究的目的:
- 提供关于cSCC病变的全面概述.
- 要突出分子点和cSCC的治疗方法.
- 讨论在cSCC治疗中的挑战和未来方向.
主要方法:
- 关于cSCC分子病原学的当前文献的综述.
- 强调失调的信号通路和分子造型.
- 对分子标,治疗剂和抵抗机制的分析.
主要成果:
- 确定了参与cSCC发展的关键信号通路.
- 讨论了针对性的疗法,如EGFR和刺抑制剂.
- 探索抵抗机制和克服它们的策略.
结论:
- 对个性化cSCC治疗来说,分子分析非常重要.
- 向治疗为传统治疗提供了有希望的替代方案.
- 需要进一步的研究来优化cSCC管理和克服阻力.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520


